Abstract
In clinical practice, tegafur, gimeracil, and oteracil potassium (S-1) therapy is commonly administered to treat nasopharyngeal carcinoma (NPC). Howev......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
